Kerala High Court Reviews Controversy Over 'Dr.' Title for Physiotherapists
Synopsis
Key Takeaways
Kochi, March 2 (NationPress) The Kerala High Court has accepted the appeals lodged by the Indian Medical Association (IMA) and the Indian Association of Physical Medicine and Rehabilitation (IAPMR) that contest a recent ruling by a Single Bench, which allowed physiotherapists, in addition to medical professionals, to use the title “Dr.” before their names.
A Division Bench led by Justice Sushrut Arvind Dharmadhikari and Justice P.V. Balakrishnan has issued notices to the involved parties following preliminary discussions, indicating that this issue merits thorough examination.
The hearing is scheduled for March 19.
This controversy arose from a decision that granted physiotherapists the right to use the “Dr.” prefix, a move that has faced opposition from various segments of the medical community.
The IMA and IAPMR argue that allowing non-MBBS practitioners to adopt the title could create confusion among patients and obscure professional boundaries in clinical environments.
During last week’s proceedings, the Division Bench noted that deciding who is eligible to use the “Dr.” title may not be exclusively within the judicial scope.
The Bench suggested that such a policy decision should be made by the government or legislature, which can establish clear regulatory guidelines after evaluating professional qualifications and statutory regulations.
The matter was postponed to allow senior counsel representing the appellants to gather instructions regarding the pursuit of the appeals in light of the court’s comments.
On Monday, the counsel informed the Bench that the appellants were keen to continue with their case, presenting all available legal and regulatory arguments.
Recognizing this submission, the court acknowledged that the matters at hand require in-depth discussions and formal adjudication.
The March 19 session is anticipated to involve extensive debates on the relevance of professional titles, the authority of regulatory bodies, and the possible public interest ramifications stemming from the usage of the “Dr.” prefix across various health disciplines.